A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors
Clinical trial NCT07623707 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07623707
- Sponsor
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-12-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.